Gene Query: ARL2

Dataset Description Geneva Score
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 64.34
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 43.57
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 31.4
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 29.18
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 24.18
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 23.09
Gene expression analysis of the impact of TDP-43 knockout in human cells. 23.09
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 22.8
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 21.18
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 20.69
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 19.12
Loss of CREBBP results in gene expression repression in lymphoma cells 19.08
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 19.08
RNA-seq of shEZH2 cells 18.96
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 18.82
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 18.2
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 17.53
Seletive inhibition of CDK9 in DLBCL cell lines 16.83
Effect of PRDM11 depletion in U2932 cells 16.77
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 16.68
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 16.26
A transcriptome-wide divergence in protein translation scales with LIN28B expression 15.97
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 15.95
RNA-seq in transgenic cells 15.85
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 15.41
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 15.33
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 15.25
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 15.11
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 14.71
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 14.61
RNA-seq analysis of uveal melanoma cells treated with FR900359 14.57
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 14.39
miR941 overexpression experiment 14.06
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 13.7
Single-nucleotide-resolution mapping of HBV promoters using CAGE 13.57
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 13.51
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 13.2
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 13.19
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 13.19
Identification of transcription start sites for human A549 cell line using ReCappable-seq 13.08
Ectoderm specification of H1 human embryonic stem cells 13.01
Genetic-to-epigenetic Therapy for Pancreatic Cancer 12.92
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 12.9
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 12.82
Fbxo32 mediated gene expression program underlies EMT and metastasis 12.79
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 12.74
RNA-seq of young and quiescent MRC-5 human fibroblasts 12.6
Functional role of SLIT2 and ROBO1 in trophoblasts 12.38
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 12.22
Characterization of parental and rociletinib-resistant derived H1975 cell lines 12.16
The regulartory role of ZCCHC24 in splicing machinery 11.89
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 11.86
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 11.73
Gene expression profiling of leukemia cells following asparagine depletion 11.66
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 11.62
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 11.62
Control of prostate tumour growth by the long non-coding RNA GHSROS 11.56
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 11.51
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 11.51
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 11.43
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 11.41
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 11.39
Global analysis of enhancer targets: Mosaic-seq 11.21
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 11.1
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 11.05
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 10.99
Differential gene expression of human melanoma cells [RNA-seq] 10.99
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 10.99
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 10.83
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures 10.78
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 10.72
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 10.72
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 10.62
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 10.61
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 10.59
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 10.58
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 10.58
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 10.53
Hijacking of stress response machinery by oncogenes in acute leukaemia 10.5
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 10.5
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 10.47
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 10.44
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 10.23
hTERT promotes cell adhesion and migration independent of telomerase activity 10.23
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 10.18
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 10.18
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 10.18
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 10.17
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 10.07
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 10.05
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 10.05
RNA-seq of human aneuploid cell lines with Trisomy 21 9.91
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 9.86
Survival of pancreatic cancer cells lacking KRAS function 9.85
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 9.84
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 9.84
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 9.84
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 9.84
Mutational landscape of splicing genes and functional consequences across 33 cancer types 9.82
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 9.79
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 9.76
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 9.76
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 9.68
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 9.68
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 9.63
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 9.6
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 9.55
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 9.52
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 9.52
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 9.49
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 9.41
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 9.34
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 9.24
Generating Patterned Kidney Organoids for Studying Development and Diseases 9.23
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 9.19
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 9.19
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 9.19
Impact of dieldrin on transcription in Jurkat T cells 9.13
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 9.12
A sister of NANOG regulates genes expressed in pre-implantation human development 9.11
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 9.11
Co-regulation of splicing by Rbfox1 and hnRNP M 9.1
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 9.1
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 9.06
Targeting MTHFD2 in Acute Myeloid Leukemia 9.05
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 8.96
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 8.91
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 8.82
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 8.82
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 8.82
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 8.75
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 8.74
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 8.72
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 8.7
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 8.6
A novel target of EZH1/2 for treatment of mantle cell lymphoma 8.56
IDH3a KO RNA-seq 8.54
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 8.5
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 8.48
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 8.47
Identification of global regulators of T-helper cell lineage specification 8.47
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 8.46
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 8.37
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 8.37
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 8.35
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 8.34
Functional role of CPPED1 in trophoblasts. 8.32
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 8.26
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 8.18
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 8.17
RNA expression analysis upon JMJD1C depletion 8.17
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 8.17
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 8.15
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 8.13
Differential gene expression profiles in imatinib-resistant cell lines 8.12
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 8.06
DIGIT regulates endoderm differentiation of human embryonic stem cells 7.99
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 7.99
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 7.96
Glioblastoma stem cells infected by ZIKA virus 7.87
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 7.73
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 7.73
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 7.71
RNAseq Analysis in glioblastoma cells treated with Mepazine 7.68
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 7.67
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 7.66
RNA-seq of naive and primed ES cells (NHSM) 7.62
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 7.61
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 7.54
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 7.53
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 7.53
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 7.49
Downregulation of DDX5/DDX17 and REST 7.46
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 7.44
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 7.44
TGF-β regulation of miRNA expression in pancreatic cancer 7.41
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 7.4
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 7.4
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 7.4
Transcriptome sequencing of K-562 cells 7.33
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 7.28
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 7.25
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 7.25
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 7.25
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 7.16
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 7.07
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 7.05
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 7.0
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 6.98
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 6.95
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 6.94
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 6.93
Cell responses to dysregulated VZV-induced cell-cell fusion 6.93
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 6.9
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 6.87
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 6.85
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 6.84
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 6.83
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 6.81
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 6.8
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 6.77
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 6.77
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 6.76
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 6.75
CROP-Seq in Primary Human T Cells 6.71
High-throughput sequencing of pluripotent cells 6.69
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 6.68
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 6.68
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 6.65
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 6.59
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 6.56
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 6.55
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 6.55
Regulation of highly expressed hCINAP on translatome 6.54
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 6.53
HEK293 TFAM Knockout Expression Study 6.52
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 6.49
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 6.47
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 6.46
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 6.41
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 6.41
Role of XRN2 ribonucleolytic activity in RNA metabolism 6.4
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 6.39
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 6.37
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 6.32
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 6.24
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 6.23
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 6.22
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 6.2
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 6.2
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 6.11
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 6.1
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 6.1
scRNASeq analysis of cycling cardiomyocytes 6.06
Cerebellar differentiation in Ataxia-Telangiectasia 6.01
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 5.98
Accurate annotation of human protein-coding small open reading frames 5.97
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 5.97
The age and genomic integrity of neurons after cortical stroke in humans 5.94
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 5.93
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 5.92
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 5.92
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 5.92
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 5.92
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 5.88
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 5.87
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 5.86
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 5.84
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 5.83
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 5.83
Dissecting neural differentiation regulatory networks through epigenetic footprinting 5.82
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 5.81
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 5.78
RNA-seq analysis of RALD iPSCs after in vitro differentiation 5.72
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 5.71
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 5.71
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 5.68
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 5.67
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 5.67
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 5.65
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 5.64
Aneuploidy-induced cellular stresses limit autophagic degradation. 5.62
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 5.62
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 5.62
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 5.59
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 5.58
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 5.56
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 5.54
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 5.54
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 5.51
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 5.45
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 5.33
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 5.3
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 5.24
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 5.24
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 5.22
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 5.17
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 5.15
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 5.08
Gene expression signatures of innate lymphoid cells from human blood 5.08
Differentiation enhances Zika virus infection in neuronal brain cells 4.99
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 4.93
CDK4/6 inhibitor resistance in prostate cancer 4.91
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 4.91
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 4.89
MCF10A H-Ras RNA-Seq 4.85
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 4.85
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 4.84
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 4.8
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 4.7
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 4.62
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 4.58
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 4.56
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 4.56
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 4.51
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 4.5
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 4.48
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 4.45
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 4.45
Ribosomal protein RPL26 is the principal target of UFMylation 4.44
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 4.42
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 4.41
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 4.39
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 4.38
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 4.38
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 4.36
Oncogenic roles of ARID5B in T-ALL 4.36
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 4.36
RNA editing in nascent RNA affects pre-mRNA splicing 4.33
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 4.3
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 4.29
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 4.29
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 4.24
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 4.22
PRDM1 inhibits proliferation of human colon cancer organoids 4.22
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 4.19
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 4.15
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 4.05
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 4.01
CD86 regulates a pro-survival signal in myeloma cells 4.0
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 3.97
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 3.95
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 3.94
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 3.94
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 3.93
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 3.92
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 3.87
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 3.87
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 3.78
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 3.78
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 3.76
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 3.71
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 3.71
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 3.71
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 3.7
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 3.7
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 3.62
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 3.6
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 3.58
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 3.54
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 3.52
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 3.52
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 3.47
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 3.45
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 3.41
RNAseq of cell lines with knocked in ESR1 mutations 3.41
Human Treg NaCl stimulation 3.4
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 3.38
Illumina Total RNA-seq in HeLa 3.38
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 3.36
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 3.32
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 3.32
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 3.3
Transcriptional effect of ETV1 knockdown in melanoma cells 3.26
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 3.22
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 3.19
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 3.17
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 3.11
Profiling of escape kinetics of viruses subjected to RNAi 3.1
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 3.07
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 3.07
EWSR1 influences alternative splicing through direct and indirect mechanisms 3.06
Positively selected enhancer elements endow tumor cells with metastatic competence 2.99
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 2.98
Bone marrow derived human B cells [normal proB] 2.93
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 2.91
The transcriptome effect of overexpressing EZH2 in MCF7 2.9
Ribosome profiling upon inhibition of eIF4A 2.82
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 2.8
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 2.76
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 2.76
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 2.76
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 2.76
A transcriptome dataset revealing the molecular features of breast cancer stem cells 2.75
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 2.7
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 2.65
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 2.62
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 2.58
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 2.57
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 2.55
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 2.47
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 2.44
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 2.41
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 2.41
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 2.41
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 2.4
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 2.32
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 2.28
m6A-dependent regulation of messenger RNA stability 2.24
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 2.13
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 2.06
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 2.05
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 2.04
N6-methyladenine DNA Modification in Glioblastoma 2.01
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 2.01
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 1.94
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 1.93
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 1.91
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 1.9
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 1.88
The bromodomain protein BRD4 regulates splicing during heat shock 1.87
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 1.8
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 1.8
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 1.79
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 1.78
SRSF1 role in cellular gene expression and splicing 1.77
Functional significance of the HIV-1 Tat signature amino acid residues 1.68
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 1.68
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 1.68
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 1.67
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 1.63
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 1.62
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 1.6
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 1.57
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 1.56
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 1.56
Gene expression regulated by CSA and CSB in neuroblastoma cell line 1.54
Comparative Analysis of Cas9 Activators Across Multiple Species 1.52
RNA-Seq of PRMT1 overexpression ECA109 cells 1.48
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 1.41
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 1.39
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 1.37
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 1.36
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 1.32
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 1.32
Function and hormonal regulation of GATA3 in human first trimester placentation 1.3
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 1.29
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 1.23
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 1.23
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 1.23
Global transcriptome analysis of WT versus HEB-/- hESCs 1.21
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 1.2
mRNA differential expression analysis in a human ex vivo model of chronic wounds 1.18
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 1.17
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 1.17
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 1.15
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 1.13
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 1.06
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 1.03
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 1.02
Epigenomic conservation of transposable element silencing 1.0
Epigenomic conservation of transposable element silencing [RNA-seq] 1.0
Impact on erythroid progenitor type on erythroid differntiation 0.98
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 0.97
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 0.97
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 0.95
RNA seq with AML (NB4) cells upon FTO inhibition 0.95
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 0.93
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.92
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  0.9
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.8
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.8
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.79
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 0.78
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.78
Expression charcaterization of an internal protocol developed to differentiate RPE cells 0.73
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 0.71
Enhancer activation during EGF response 0.71
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 0.69
Dermal endothelial cells of type 2 diabetic patients 0.69
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 0.68
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 0.68
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 0.63
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 0.63
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.61
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.6
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.6
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.57
EWS-Fli and LNC regulated genes in comparison to GFP samples 0.56
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 0.56
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 0.56
Effects of transcription on genome - nuclear lamina interactions 0.56
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.55
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.52
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.48
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.47
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.44
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.44
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 0.42
Transcriptional changes in lymphoma cells induced by LSD1 depletion 0.42
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 0.4
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 0.39
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.39
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.39
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 0.37
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 0.35
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 0.32
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 0.3
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 0.3
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 0.29
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 0.29
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 0.14
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 0.12
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 0.11
Induced DNA demethylation, genome instability and transcription 0.11
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 0.11
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.09
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.09
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.07
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.06


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation